Gursewa Dialysis India Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 28-12-2024
- Paid Up Capital ₹ 0.50 M
as on 28-12-2024
- Company Age 3 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.20 Cr
as on 28-12-2024
- Revenue 98.72%
(FY 2023)
- Profit -38.18%
(FY 2023)
- Ebitda 47.76%
(FY 2023)
- Net Worth 31.53%
(FY 2023)
- Total Assets 928.93%
(FY 2023)
About Gursewa Dialysis India
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹3.20 Cr.
Anuradha Nayuni, Raneanathan Venkatesh, and Anitha Talgeri serve as directors at the Company.
- CIN/LLPIN
U85300DL2021PLC384867
- Company No.
384867
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
06 Aug 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Gursewa Dialysis India?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anuradha Nayuni  | Director | 06-Aug-2021 | Current |
| Raneanathan Venkatesh | Director | 06-Aug-2021 | Current |
| Anitha Talgeri | Director | 18-Nov-2022 | Current |
Financial Performance of Gursewa Dialysis India.
Gursewa Dialysis India Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 98.72% increase. The company also saw a substantial fall in profitability, with a 38.18% decrease in profit. The company's net worth Soared by an impressive increase of 31.53%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gursewa Dialysis India?
In 2023, Gursewa Dialysis India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Philanthropy Dialysis Innovation LlpActive 3 years 6 months
Raneanathan Venkatesh is a mutual person
- Prashanthi Mandir Dialysis & Cancer FoundationActive 1 year 7 months
Raneanathan Venkatesh is a mutual person
Charges (Loans)
₹32.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 3.20 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Jul 2023 | Others | ₹2.17 Cr | Open |
| 02 Aug 2022 | Others | ₹1.03 Cr | Open |
How Many Employees Work at Gursewa Dialysis India?
Gursewa Dialysis India has a workforce of 0 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gursewa Dialysis India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gursewa Dialysis India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
